Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
Status:
Terminated
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
Multi-center, double-blind, placebo-controlled, randomized, parallel study comparing
continuous intravenous (IV) Remodulin® to placebo in patients with pulmonary arterial
hypertension either primary (PPH) or associated with human immunodeficiency virus (HIV)
infection or collagen vascular disease).